Denosumab versus zoledronic acid in patients previously treated with zoledronic acid

被引：0
|
作者：
A. D. Anastasilakis
S. A. Polyzos
A. Gkiomisi
Z. G. Saridakis
D. Digkas
I. Bisbinas
G. T. Sakellariou
A. Papatheodorou
P. Kokkoris
P. Makras
机构：
[1] 424 General Military Hospital,Department of Endocrinology
[2] Aristotle University of Thessaloniki,Second Medical Clinic, Department of Medicine, Ippokration General Hospital
[3] 424 General Military Hospital,Department of Obstetrics and Gynaecology
[4] Hellenic Military School of Medicine,1st Department of Orthopaedics
[5] 424 General Military Hospital,Department of Rheumatology
[6] 424 General Military Hospital,Department of Medical Research
[7] 251 Hellenic Air Force & VA General Hospital,Department of Endocrinology and Diabetes
[8] 251 Hellenic Air Force & VA General Hospital,undefined
来源：
Osteoporosis International | 2015年 / 26卷
关键词：
Bone mineral density; Bone turnover markers; Denosumab; RANKL; Sclerostin; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2521 / 2527
页数：6
相关论文
共 50 条
  • [1] Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
    Anastasilakis, A. D.
    Polyzos, S. A.
    Gkiomisi, A.
    Saridakis, Z. G.
    Digkas, D.
    Bisbinas, I.
    Sakellariou, G. T.
    Papatheodorou, A.
    Kokkoris, P.
    Makras, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (10) : 2521 - 2527
  • [2] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [3] Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
    Riesco Barcena, Carmen
    Ivorra Cortes, Jose
    Grau Garcia, Elena
    Leal Rodriguez, Samuel
    Gonzalez Puig, Luis
    Huaylla Quispe, Anderson Victor
    Munoz Martinez, Pablo Francisco
    Torrat Noves, Alba Maria
    Ramos Castro, Daniel
    Mas Sanchez, Laura
    Canovas Olmos, Ines
    Charia, Hikmat
    Martinez Cordellat, Isabel
    Najera Herranz, Carmen
    Negueroles Albuixech, Rosa
    Oller Rodriguez, Jose Eloy
    De la Rubia Navarro, Marta
    Tovar Sugranes, Ernesto
    Vicens Bernabeu, Elvira
    Alcantara Alvarez, Iago
    Villanueva Manez, Belen
    Roman Ivorra, Jose Andres
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3986 - 3988
  • [4] The effect of denosumab on kidney function in patients with metastatic breast cancer to bone previously treated with zoledronic acid
    Purvey, Sneha
    Leventakos, Konstantinos
    Munjoma, Mutsa S.
    Sherman, Michael J.
    Desale, Sameer
    Herbolshelmer, Pla Maarit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Denosumab versus zoledronic acid in elderly patients after hip fracture
    Kim, Seung-Ju
    Kim, Ji Woon
    Lee, Dong-Woo
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY, 2022, 30 (03)
  • [6] OVERALL SURVIVAL (OS) IMPROVEMENT IN PATIENTS WITH LUNG CANCER TREATED WITH DENOSUMAB VERSUS ZOLEDRONIC ACID (ZA)
    Glennane, A.
    Lipton, L.
    Scagliotti, G.
    Hirsh, V
    Siena, S.
    Henry, D.
    Woll, P.
    Manegold, C.
    Solal-Celigny, P.
    Rodriguez, G.
    Krzakowski, M.
    Mehta, N. D.
    Garcia-Saenz, J. A.
    Pereira, J.
    Prabhash, K.
    Tudor-Eliade, C.
    Kanarev, V
    Feng, A.
    Jacobs, I
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S168 - S168
  • [7] Antineoplastic Activity of Zoledronic Acid and Denosumab
    Zwolak, Pawel
    Dudek, Arkadiusz Z.
    [J]. ANTICANCER RESEARCH, 2013, 33 (08) : 2981 - 2988
  • [8] Comparative Safety and Effectiveness of Denosumab versus Zoledronic Acid in Patients with Osteoporosis: A Cohort Study
    Choi, Nam-Kyong
    Solomon, Daniel H.
    Tsacogianis, Theodore N.
    Landon, Joan E.
    Song, Hong Ji
    Kim, Seoyoung C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 272 - 273
  • [9] Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study
    Choi, Nam-Kyong
    Solomon, Daniel H.
    Tsacogianis, Theodore N.
    Landon, Joan E.
    Song, Hong Ji
    Kim, Seoyoung C.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (03) : 611 - 617
  • [10] Treatment with zoledronic acid subsequent to treatment with denosumab
    Solling, Anne Sophie
    Harslof, Torben
    Langdahl, Bente Lomholt
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 60 - 60
12345